ClinicalTrials.govpublic full text
Repurposing Siponimod for Alzheimer's Disease
alzheimer disease, mild alzheimer disease, mci with increased risk for alzheimer disease, cognitive impairment, mild, alzheimer's disease, siponimod, cognitive impairment, cognition, brain imaging, biomarkers, immunomodulation, interventional
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 877101
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.